当前位置: X-MOL 学术Hepatology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Response to “Serum bioavailable 25-hydroxyvitamin D levels correlate with hepatocellular carcinoma survival”
Hepatology ( IF 12.9 ) Pub Date : 2021-09-18 , DOI: 10.1002/hep.32160
Ai-Ping Fang 1, 2 , Yao-Jun Zhang 3, 4 , Min-Shan Chen 3, 4 , Hui-Lian Zhu 1, 2
Affiliation  

We appreciate the interest of Zhai and colleagues in our article recently published in Hepatology on the association between serum levels of total, free, and bioavailable 25-hydroxyvitamin D (25OHD) and hepatocellular carcinoma (HCC) survival(1). They raised three important points, especially the last two, which allow us to further evaluate the predictive performance of bioavailable 25OHD for HCC prognosis.

中文翻译:

对“血清生物可利用的 25-羟基维生素 D 水平与肝细胞癌存活率相关”的回应

我们感谢 Zhai 及其同事对我们最近在 Hepatology 上发表的关于血清总水平、游离水平和生物可利用度 25-羟基维生素 D (25OHD) 与肝细胞癌 (HCC) 存活率之间关联的文章的兴趣 (1 )。他们提出了三个要点,尤其是最后两个,这使我们能够进一步评估生物可利用的 25OHD 对 HCC 预后的预测性能。
更新日期:2021-09-19
down
wechat
bug